SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-002439
Filing Date
2020-02-03
Accepted
2020-02-03 17:28:57
Documents
8
Period of Report
2020-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k013020_intecpharma.htm 8-K 34037
2 UNDERWRITING AGREEMENT, DATED JANUARY 30, 2020,BY AND BETWEEN THE COMPANY AND H. f8k013020ex1-1_intecpharma.htm EX-1.1 246365
3 FORM OF WARRANT f8k013020ex4-1_intecpharma.htm EX-4.1 122574
4 FORM OF PRE-FUNDED WARRANT f8k013020ex4-2_intecpharma.htm EX-4.2 100030
5 OPINION OF MEITAR | LAW OFFICES f8k013020ex5-1_intecpharma.htm EX-5.1 10202
6 OPINION OF MCDERMOTT WILL & EMERY LLP f8k013020ex5-2_intecpharma.htm EX-5.2 16959
7 GRAPHIC ex5-1_001.jpg GRAPHIC 27450
8 GRAPHIC ex5-2_001.jpg GRAPHIC 4526
  Complete submission text file 0001213900-20-002439.txt   575595
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 20569803
SIC: 2834 Pharmaceutical Preparations